Dexcom reports 15% YoY revenue uptick in Q1 yet maintains prior FY26 outlook
Summary
Dexcom has opted not to raise its FY26 revenue outlook due to the current geopolitical environment.
Original reporting
Open original sourceAFBytes is a read-only aggregator. Use the original source for full context and complete reporting.